in individual high-risk circumstances, such as triple-positive aPL or strongly positive LAC results, advanced maternal age, or IVF pregnancy, may outweigh risks of this therapy, and decisions should be made with discussion between physician and patient, weighing potential risks and benefits. Other therapies for refractory OB APS. Despite improved outcomes with standard therapy with low-dose aspirin and prophylactic heparin/LMWH, additional treatments are needed for patients who do not respond